We use cookies to give you the best experience possible with our website and to improve our communication with you. We consider your selection and will only use the data you have approved us to gather.

These cookies help making a website usable by enabling basic functions like page navigation and access to secure areas of the website. The website cannot function properly without these cookies.

These cookies help website owners to understand how visitors interact with websites by collecting and reporting information anonymously. With this information we can constantly improve the experience we offer on our website.

These cookies are used to track visitors across websites. The intention is to display ads that are relevant and engaging for the individual user and thereby more valuable for publishers and third party advertisers.

Geistlich vallomixTM

The first xenogeneic/allogeneic validated bone substitute1

Now we’re making it easier for you to combine two validated regenerative materials for restoring vital bone faster2 – with the proven long-term volume stability you rely on.

Bringing together the verified osteoinductivity of vallos allograft1 with the volume stability of Geistlich Bio-Oss®.3-8

Conveniently packaged Geistlich vallomix contains Geistlich Bio-Oss® granules and vallos granules or fibers. Together, these proven products bring optimal consistency and performance1-14 in demanding clinical situations.

Validated • Allograft • Osteoinductive • Selection

 

 

vallosTM – Osteoinductive Potential

Verified vallos granules and fibers are allogeneic bone grafts that have been demineralized to ensure high osteoinductive properties.1 A demineralized bone matrix has the advantage of turning over natural bone more rapidly but lacks the volume stability needed in a number of clinical situations.

The selection process of vallos involves thorough review and validated lot testing to ensure:

  • Consistent product quality1
  • Verified osteoinductive potential, validated test method1
  • Demineralized allografts have shown vital bone after 18-20 weeks2

 

 

Geistlich Bio-Oss® – Volume Stability

Geistlich Bio-Oss® is the leading xenogeneic bone substitute worldwide, with more than 35 years of scientific validation. It is the ideal biomaterial that consistently maintains bone volume over time.3-8

With each vial of Geistlich Bio-Oss®, you are assured a treatment solution with:

  • Demonstrated clinical success9
  • Optimal scaffold for vascularization and new bone formation10-13
  • Long-term volume stability3-8

 

 

References:

  1. Compiled DCI Osteoinductivity Validation Summary_2020. (data on file)
  2. Robert A Wood & Brian L Mealey: J Periodontol. 2012 Mar;83(3):329-36. (Clinical Study)
  3. Piattelli M et al.: Int J Oral Maxillofac Implants 1999; 14 (6), 835-40. (Clinical Study).
  4. Sartori S et al.: Clin Oral Implants Res 2003; 14 (3), 369-72. (Clinical Study).
  5. Maiorana C et al.: Int J Periodontics Restorative Dent 2005; 25 (1), 19-25. (Clinical Study).
  6. Orsini G et al.: Oral Dis 2007; 13 (6), 586-93. (Clinical Study).
  7. Lindgren C et al.: Int J Oral Maxillofac Implants 2009; 24 (6), 1093-100. (Clinical Study).
  8. Mordenfeld A et al.: Clin Oral Implants Res 2010; 21 (9), 961-70. (Clinical Study).
  9. Serrano CA et al.: Implant Dent. 2018 Aug; 27(4):467-473. (Clinical Study).
  10. NCBI Pubmed, Month Year, Search term “Bio-Oss” (1208 hits) (Market research).
  11. Berglundh T & Lindhe J: Clin Oral Implants Res 1997; 8 (2), 117-24. (Preclincal Study).
  12. Weibrich G et al.: Mund Kiefer Gesichtschir 2000; 4 (3), 148-52. (Preclincal Study).
  13. Degidi M et al.: Oral Dis 2006; 12 (5), 469-75. (Clinical Study).
  14. Galindo-Moreno P et al.: Clin Oral Implants Res 2010; 21 (2), 221-7. (Clinical Study).
  15. Data on file, Geistlich Pharma AG, Switzerland

 

CAUTION: Federal law restricts these devices to sale by or on the order of a dentist or physician.